Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma.
about
Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomesIsotretinoin, pregnancies, abortions and birth defects: a population-based perspectiveUse of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmaticsEpidemiology and management of common pulmonary diseases in older personsVBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in miceEffects of inhaled fluticasone on intraocular pressure and central corneal thickness in asthmatic children without a family history of glaucoma.Transcriptional potencies of inhaled glucocorticoids.Montelukast: data from clinical trials in the management of asthma.Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 updateAllergic rhinitis and rhinosinusitis. Is there a connection between allergy and infection?Inhaled CorticosteroidsFortnightly review: modern drug treatment of chronic asthma.Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence.Inhaled and nasal corticosteroids: safety aspects.Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.Features of asthma in the elderly.Clinical practice guideline: Allergic rhinitis.Inhaled corticosteroids and the risk of diabetes among the elderlyGlucocorticoids and rheumatoid arthritis: back to the future?Combined budesonide/formoterol turbuhaler treatment of asthma.Systemic effects of inhaled corticosteroids: an overview.Withdrawal of inhaled corticosteroids in individuals with COPD--a systematic review and comment on trial methodology.Use of inhaled corticosteroids following discharge from an emergency department for an acute exacerbation of asthma.Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide.How pharmacogenomics will play a role in the management of asthma.Corticosteroid-induced glaucoma: a review of the literature.Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality.Randomized trial of acupoints herbal patching in Sanfu Days for asthma in clinical remission stage.Bioengineered glaucomatous 3D human trabecular meshwork as an in vitro disease model.Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.The effect of long-term use of intranasal steroids on intraocular pressure.Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats.Risk of adverse gastrointestinal events from inhaled corticosteroids.Inhaled corticosteroids in COPD and the risk of serious pneumonia.THE PARADOXICAL EFFECT ON PNEUMONIA OF CHRONIC INHALED CORTICOSTEROIDS.Safety and efficacy of inhaled corticosteroids (ICS) in children with asthma.The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study.Increased risk of open-angle glaucoma following chronic rhinosinusitis: a population-based matched-cohort study.
P2860
Q22306079-B5513E9F-06FA-4C54-BE2B-62A6698B1505Q24676609-82E55169-8200-46D2-9CF8-A92308560CEEQ28066822-96FACEE0-3A2A-43BD-960C-AED8113D258FQ28397465-3A39B092-F903-4EE3-B688-4BC326C871CCQ28487685-F5B6803E-19A3-4076-847F-2AE51202DB40Q30465495-AE2F952D-260C-428C-9621-56033782938AQ31409970-58B57E23-60FA-442C-8FBD-993793D2DA77Q31448541-B1E103F5-BD58-439D-9FFF-00F7654C2B33Q33591899-5ED09417-C325-4260-BF5C-B2C84B2D8634Q33605228-F08257A7-6F20-4C13-A203-FDE88EB7D6A5Q33664193-4B9F1E11-1263-43D3-A234-A41263861480Q33793696-B3AB831B-A6C7-4049-BD3B-682BD37FA2C8Q33834757-1E68CE23-0579-4C0F-8FF2-A47EDD497C4EQ33851527-19C06662-A2E9-4534-A292-D20FA2142C9BQ33976334-079FC516-A0DD-4955-8339-FDC1D1C9393AQ34065276-26A2BE5D-5CBA-4D5B-A034-3F94BFBFCD8AQ34080132-3A58E0C8-9559-4416-B6A5-1A333D0748DEQ34342751-CD9B26F2-ACCE-419A-8861-6531CDA12CACQ34460983-12A47DF5-3B6B-4620-8B71-197E0C74C735Q34524994-0CBBC0BA-F102-4FB0-BD2C-E9AC7D60CB1CQ34972556-432A5743-47A9-43BD-9414-A6CCD07AB7BDQ35009462-C4867648-92CC-4B8E-96C6-6FFDA3BA5E86Q35056155-4646E33B-2EF0-40CE-9EB9-2ECB0EEBBA71Q35257612-5EFC9F4A-47FA-4C7A-9EF4-6812A539CADFQ35536288-129FA86A-46A7-4BAA-95F0-419F0AEE8441Q35564141-A9EEF64D-29FA-4D45-9C6E-31E2175FE9FEQ36075209-7A6F6810-E227-444F-BF15-ED068DF3DB5BQ36118249-B1AFF049-068C-4BEE-9F90-F0B1E75B1F0DQ36421917-1F5740CC-0EAE-48FF-934E-9A9C63E75C50Q36547535-A09EB8DF-B008-4A37-BE8E-B6BD4D75635BQ36863008-B6A99307-8578-47D3-B9C3-682E9BC610C7Q36874335-EA657D61-E57F-4F15-8C78-6A697BE30AD7Q37012191-4F4D39CA-AB8D-4E22-9124-BEFA33EBBCF0Q37059858-211EB4DE-75A1-44F3-B196-37988F8F9298Q37111058-C762E0D2-8CB1-4204-A93D-6B9968F807C2Q37267655-0FFEED2F-A983-4109-846D-8197807801EBQ37308633-48C57A0C-C790-40C9-A02C-365A99DB1766Q37353978-5583E011-D76A-4932-9C17-0D82EFE8F5DCQ37412962-BD4DBAAC-EBBC-489A-B0AD-7189ACF8F55AQ37595072-91E691E1-4EE8-4E8E-BBFF-98BA2D7F1AFB
P2860
Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Inhaled and nasal glucocortico ...... ension or open-angle glaucoma.
@ast
Inhaled and nasal glucocortico ...... ension or open-angle glaucoma.
@en
Inhaled and nasal glucocortico ...... ension or open-angle glaucoma.
@nl
type
label
Inhaled and nasal glucocortico ...... ension or open-angle glaucoma.
@ast
Inhaled and nasal glucocortico ...... ension or open-angle glaucoma.
@en
Inhaled and nasal glucocortico ...... ension or open-angle glaucoma.
@nl
prefLabel
Inhaled and nasal glucocortico ...... ension or open-angle glaucoma.
@ast
Inhaled and nasal glucocortico ...... ension or open-angle glaucoma.
@en
Inhaled and nasal glucocortico ...... ension or open-angle glaucoma.
@nl
P2093
P1476
Inhaled and nasal glucocortico ...... ension or open-angle glaucoma.
@en
P2093
P304
P356
10.1001/JAMA.1997.03540330044033
P407
P577
1997-03-01T00:00:00Z